IP Library Granted Patent US 11,899,010
Granted Patent B2
US 11,899,010 · App. 17/664,790 · Granted Feb 13, 2024

Modular point-of-care devices, systems, and uses thereof

Inventors: Tammy Burd (Palo Alto, CA); Ian Gibbons (Portola Valley, CA); Elizabeth A. Holmes (Palo Alto, CA); Gary Frenzel (Palo Alto, CA); Anthony Joseph Nugent (Palo Alto, CA)
Assignee: Labrador Diagnostics LLC
G01N33/5304A61B5/15A61B5/151A61B5/150755B01J19/0046B01L3/0262B01L3/5025B01L3/527B01L7/52B01L9/543G01N1/38G01N33/5302G01N33/54326G01N33/54366G01N33/54386G01N33/56966G01N33/57484G01N33/6803G01N33/94G01N35/00732G01N35/00871G01N35/028G01N35/10G01N35/1065G01N35/1074G16H10/40A61B10/007A61B10/0038A61B10/0045A61B10/0051A61B10/0058A61B10/02A61B2010/0074A61B2010/0077B01J2219/005B01J2219/00283B01J2219/00292B01J2219/00315B01J2219/00369B01J2219/00371B01J2219/00385B01J2219/00466B01J2219/00495B01J2219/00693B01J2219/00702B01L3/021B01L7/5255B01L2200/04B01L2200/0689B01L2200/141B01L2200/148B01L2300/0654B01L2300/0829B01L2300/1805B01L2400/043G01N2035/0097G01N2035/00237G01N2035/00851G01N2035/00881G01N2035/1032G01N2035/1034G01N2035/1048G01N2333/475G01N2333/4737G01N2333/71G01N2333/912G01N2333/9129G01N2333/91205G01N2800/26G01N2800/60Y10T29/49826Y10T436/25375
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,899,010
App. No.
17/664,790
Granted
Feb 13, 2024
Kind
B2
Abstract

The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.

Claims (41)

1. A system for performing an assay capable of detecting an analyte in a biological sample, the system comprising:

a cartridge comprising:

a plurality of reagent units, wherein one or more of the plurality of reagent units are configured to store cartridge reagents, and

a sample vessel configured to receive the biological sample;

an assay assembly comprising:

an addressable assay unit configured to receive the biological sample and to receive a first cartridge reagent from a first reagent unit of the plurality of reagent units of the cartridge,

a reaction site arranged on an interior surface of the addressable assay unit, wherein the reaction site comprises an immobilized binding reagent configured to bind with the analyte, and

an assembly tip in fluid communication with the addressable assay unit and comprising an opening, wherein the assembly tip is configured to place the addressable assay unit in fluid communication with the first reagent unit or the sample vessel of the cartridge; and

a reader assembly configured to receive the cartridge and the assay assembly, wherein the reader assembly comprises:

an automated fluid transfer device configured to move the assay assembly relative to the cartridge to selectively place the assembly tip of the assay assembly into the sample vessel or into the first reagent unit of the plurality of reagent units and to sequentially transfer the biological sample and the first cartridge reagent into the addressable assay unit via the assembly tip such that a reaction occurs that yields a signal indicative of a presence of the analyte, and

a detection assembly configured to detect the signal indicative of the presence of the analyte.

2. The system of claim 1 , further comprising a diluent unit containing a diluent.

3. The system of claim 2 , wherein the automated fluid transfer device is configured to place the biological sample and the diluent of the diluent unit into fluid communication so as to dilute the biological sample.

4. The system of claim 1 , wherein the automated fluid transfer device comprises a head configured to engage the assay assembly and to move the assay assembly relative to the cartridge.

5. The system of claim 4 , wherein the automated fluid transfer device comprises one or more pumps to aspirate and eject fluids from the cartridge.

6. The system of claim 1 , wherein the reader assembly further comprises a temperature controlled block configured to regulate a temperature within the reader assembly.

7. The system of claim 1 , wherein the sample vessel and the plurality of reagent units are arranged in a linear array.

8. The system of claim 7 , wherein the cartridge comprises an identifier configured to encode information corresponding to contents of the cartridge.

9. The system of claim 8 , wherein the first cartridge reagent comprises a luminogenic substrate.

10. The system of claim 9 , wherein one of the plurality of reagent units of the cartridge comprises a control solution comprising a known quantity of the analyte.

11. A system for performing an assay capable of detecting an analyte in a biological sample, the system comprising:

a cartridge comprising:

a plurality of reagent units, wherein one or more of the plurality of reagent units are configured to store cartridge reagents,

a sample vessel configured to receive the biological sample, wherein the plurality of reagent units and the sample vessel are arranged in a linear array, and

an identifier configured to encode information corresponding to the contents of the cartridge;

an assay assembly comprising:

an addressable assay unit configured to receive the biological sample and to receive a first cartridge reagent from a first reagent unit of the plurality of reagent units of the cartridge,

a reaction site arranged on an interior surface of the addressable assay unit, wherein the reaction site comprises an immobilized binding reagent configured to bind with the analyte, and

an assembly tip in fluid communication with the addressable assay unit and comprising an opening, wherein the assembly tip is configured to place the addressable assay unit in fluid communication with the first reagent unit or the sample vessel of the cartridge; and

a reader assembly configured to receive the cartridge and the assay assembly, wherein the reader assembly comprises:

an automated fluid transfer device configured to move the assay assembly relative to the cartridge to selectively place the assembly tip of the assay assembly into the sample vessel or into the first reagent unit of the plurality of reagent units and to sequentially transfer the biological sample and the first cartridge reagent into the addressable assay unit via the assembly tip such that a reaction occurs that yields a signal indicative of a presence of the analyte, and

a detection assembly configured to detect the signal indicative of the presence of the analyte.

12. The system of claim 11 , wherein the immobilized binding reagent comprises an antibody or an antigen.

13. The system of claim 11 , wherein the detection assembly comprises a light source.

14. The system of claim 13 , wherein the detection assembly comprises an optical detector.

15. The system of claim 14 , wherein the signal is a fluorescent signal.

16. The system of claim 15 , wherein the analyte is procalcitonin.

17. The system of claim 15 , wherein the analyte is D-dimer.

18. The system of claim 15 , wherein the analyte is a hormone.

19. The system of claim 15 , wherein the analyte is prostate specific antigen.

20. The system of claim 15 , wherein the analyte is indicative of a sexually transmitted disease selected from the group of gonorrhea, syphilis, chlamydia , nongonococcal urethritis, yeast infection, chancroid, trichomoniasis, genital herpes, HIV I, HIV II, hepatitis A, hepatitis B, hepatitis C, hepatitis G, and hepatitis caused by transfusion-transmitted virus (TTV).

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2024
From: BURD, TAMMY; GIBBONS, IAN; HOLMES, ELIZABETH A.; FRENZEL, GARY; NUGENT, ANTHONY JOSEPH
To: THERANOS, INC.
Reel/Frame 065993/0504 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2024
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 065993/0560 →
SECURITY INTEREST Recorded Jan 2, 2024
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 066174/0244 →
CHANGE OF NAME Recorded Jan 2, 2024
From: THERANOS IP COMPANY, LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 066174/0391 →
Continuity (8)
Continuation 15069843 · Mar 14, 2016
Continuation 14670200 · Mar 26, 2015
Continuation 13893258 · May 13, 2013
Continuation 13889674 · May 8, 2013
Continuation 13326023 · Dec 14, 2011
Continuation 12244723 · Oct 2, 2008
Provisional Application 60997460 · Oct 2, 2007
Related Publication 20220283150A1 · Sep 8, 2022